14
Participants
Start Date
July 31, 2003
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
CTL administration
"Adenovirus specific T cells will be given by intravenous injection from day 30 post transplant.~One infusion of Adenovirus-specific CTL given to patients at risk for Adenoviral disease after matched or mismatched unrelated or matched or mismatched related donor stem cell transplant. Four dose levels will be explored. The lowest level will be 1x dose of 5x10e6cells/m2 and the highest will be 1x dose of 1.35x10e8/m2."
National Institute of Health (NIH), Washington D.C.
Texas Children's Hospital, Houston
The Methodist Hospital, Houston
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
The Methodist Hospital Research Institute
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Baylor College of Medicine
OTHER